Verano Holdings (VRNO) Accounts Payables (2021 - 2026)
Verano Holdings' (VRNO) quarterly Accounts Payables came in at $29.0 million in Q1 2026, down 36.21% year-on-year from $45.4 million in Q1 2025, and down 25.24% on a QoQ basis from $38.7 million in Q4 2025.
Verano Holdings (VRNO) Accounts Payables (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Accounts Payables data on file, last reported at $29.0 million in Q1 2026.
- On a quarterly basis, Accounts Payables fell 36.21% year-over-year to $29.0 million in Q1 2026; TTM through Mar 2026 was $29.0 million, a 36.21% decrease from a year earlier, with the FY2025 full-year figure at $38.7 million, down 2.98% from the prior year.
- Accounts Payables for Q1 2026 stood at $29.0 million, down from $38.7 million in the prior quarter.
- Over the last five years, Accounts Payables for VRNO reached as high as $60.8 million in Q2 2022 and fell as low as $25.2 million in Q2 2024.
- Historically, Accounts Payables has averaged $38.3 million across 5 years, with a median of $39.2 million in 2025.
- Across the five-year window, Accounts Payables sank 42.91% in 2023 and jumped 60.37% in 2025, its largest moves.
- Year by year, Accounts Payables stood at $40.5 million in 2022, then retreated by 22.76% to $31.3 million in 2023, then rose by 27.64% to $39.9 million in 2024, then dropped by 2.98% to $38.7 million in 2025, then slipped by 25.24% to $29.0 million in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $29.0 million in Q1 2026, $38.7 million in Q4 2025, and $42.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 28.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.96 Mn |
| Dec 31, 2025 | 38.74 Mn |
| Sep 30, 2025 | 42.32 Mn |
| Jun 30, 2025 | 39.67 Mn |
| Mar 31, 2025 | 45.40 Mn |
| Dec 31, 2024 | 39.93 Mn |
| Sep 30, 2024 | 42.49 Mn |
| Jun 30, 2024 | 25.20 Mn |
| Mar 31, 2024 | 28.31 Mn |
| Dec 31, 2023 | 31.28 Mn |
| Sep 30, 2023 | 31.02 Mn |
| Jun 30, 2023 | 34.73 Mn |
| Mar 31, 2023 | 30.52 Mn |
| Dec 31, 2022 | 40.50 Mn |
| Sep 30, 2022 | 52.21 Mn |
| Jun 30, 2022 | 60.83 Mn |
| Dec 31, 2021 | 45.17 Mn |